Skip to main content

Table 2 Genotype and allele frequencies of rs4685 (SF3B1), rs12366395 (TBX3), rs72758040 (MAP3K1), rs8853 (TBX3), and rs1061651 (TBX3) according to number of BC cases per family in BRCA1/2-negative breast cancer cases and controls

From: Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population

  

Families with 2 BC and/or OC cases (n = 163)

Families with ≥ 3 BC and/or OC cases (n = 145)

Genotype or allele

Controls (%) (n = 1258)

BC cases (%)

OR [95% CI]

p-valuea

BC cases (%)

OR [95% CI]

p-valuea

rs4685 (SF3B1)

C/C

504 (40.1)

75 (46.0)

(Ref.)

58 (40.0)

(Ref.)

C/T

560 (44.5)

70 (42.9)

0.8 [0.5–1.1]

0.33

69 (47.6)

1.0 [0.7–1.5]

0.77

T/T

194 (15.4)

18 (11.0)

0.6 [0.3–1.0]

0.10

18 (12.4)

0.8 [0.4–1.4]

0.50

C/T + T/T

754 (59.9)

88 (53.9)

0.7 [0.5–1.0]

0.15

87 (60.0)

1.0 [0.7–1.4]

1.00

Allele C

1568 (62.3)

220 (67.5)

(Ref.)

185 (63.8)

(Ref.)

Allele T

948 (37.7)

106 (32.5)

0.7 [0.6–1.0]

0.07

105 (36.2)

0.9 [0.7–1.2]

0.67

rs12366395 (TBX3)

A/A

989 (78.6)

118 (72.4)

(Ref.)

102 (70.3)

(Ref.)

A/G

252 (20.0)

43 (26.4)

1.4 [0.9–2.0]

0.06

39 (26.9)

1.5 [1.0–2.2]

0.04

G/G

17 (1.4)

2 (1.2)

0.9 [0.2–4.3]

1.0

4 (2.8)

2.2 [0.7–6.9]

0.1

A/G + G/G

269 (21.4)

45 (27.6)

1.4 [0.9–2.0]

0.08

43 (29.7)

1.5 [1.0–2.2]

0.02

Allele A

2230 (88.6)

279 (85.6)

(Ref.)

243 (83.8)

(Ref.)

Allele G

286(11.4)

47 (14.4)

1.3 [0.9–1.8]

0.1

47 (16.2)

1.5 [1.0–2.1]

0.02

rs72758040 (MAP3K1)

G/G

866 (68.8)

103 (63.4)

(Ref.)

92 (63.2)

(Ref.)

G/C

307 (24.4)

41 (25.0)

1.1 [0.7–1.6]

0.54

35 (24.3)

1.0 [0.7–1.6]

0.74

C/C

85 (6.8)

19 (11.6)

1.8 [1.0–3.1]

0.03

18 (12.5)

1.9 [1.1–3.4]

0.01

G/C + C/C

392 (31.2)

60 (36.6)

1.2 [0.9–1.8]

0.15

53 (36.8)

1.2 [0.8–1.8]

0.18

Allele G

2039 (81.0)

247 (75.9)

(Ref.)

219 (75.5)

(Ref.)

Allele C

477 (19.0)

79 (24.1)

1.3 [1.0–1.7]

0.02

71 (24.5)

1.3 [1.0–1.8]

0.03

rs8853 (TBX3)

T/T

512 (40.7)

65 (39.9)

(Ref.)

60 (41.4)

(Ref.)

T/C

563 (44.8)

70 (42.9)

0.9 [0.6–1.4]

0.92

63 (43.4)

0.9 [0.6–1.3]

0.84

C/C

183 (14.5)

28 (17.2)

1.2 [0.7–1.9]

0.45

22 (15.2)

1.0 [0.6–1.7]

0.89

T/C + C/C

746 (59.3)

98 (60.1)

1.0 [0.7–1.4]

0.86

84 (58.6)

0.9 [0.6–1.3]

0.96

Allele T

1587 (63.1)

200 (61.3)

(Ref.)

183 (63.1)

(Ref.)

Allele C

929 (36.9)

126 (38.7)

1.0 [0.8–1.3]

0.58

107 (36.9)

0.9 [0.7–1.2]

0.95

rs1061651 (TBX3)

T/T

414 (32.9)

52 (31.9)

(Ref.)

46 (31.7)

(Ref.)

T/C

596 (47.4)

77 (47.2)

1.0 [0.7–1.4]

0.92

76 (52.4)

1.1 [0.7–1.6]

0.49

C/C

248 (19.7)

34 (20.9)

1.0 [0.6–1.7]

0.72

23 (15.9)

0.8 [0.4–1.4]

0.60

T/C + C/C

844 (67.1)

111 (68.1)

1.0 [0.7–1.4]

0.85

99 (68.3)

1.0 [0.7–1.5]

0.85

Allele T

1424 (56.6)

181 (55.5)

(Ref.)

168 (57.9)

(Ref.)

Allele C

1092 (43.4)

145 (44.5)

1.0 [0.8–1.3]

0.75

122 (42.1)

0.9 [0.7–1.2]

0.71

  1. BC breast cancer, OC ovarian cancer, OR odds ratio, CI confidence interval, Ref reference
  2. aFisher’s exact test; bold values are statistically significant (p < 0.05)